Tokyo, Japan

Hidemi Masumura

This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Seiyaku Co., Ltd.. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidemi Masumura. Retrieved from https://idiyas.com/inventor/hidemi-masumura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hidemi Masumura

Introduction

Hidemi Masumura is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidiabetic agents. His work is characterized by a focus on innovative compounds that can improve health outcomes for patients.

Latest Patents

Masumura holds a patent for a compound described as an antidiabetic agent. The patent, titled "The compound, 6-(1-imidazolyl)," includes a compound represented by a specific formula. This compound features an imidazolyl group, a thiazolyl group, or a pyridyl group, with various parameters defined for its structure. The active ingredient is designed to be a pharmaceutically acceptable salt, showcasing Masumura's commitment to advancing medical science.

Career Highlights

Hidemi Masumura is associated with Daiichi Seiyaku Co., Ltd., a prominent pharmaceutical company. His role at the company has allowed him to engage in cutting-edge research and development. His innovative approach has led to the creation of valuable patents that contribute to the field of diabetes treatment.

Collaborations

Masumura has worked alongside talented colleagues, including Kyoko Sakuma and Shinichiro Ashida. Their collaborative efforts have fostered an environment of innovation and creativity, leading to advancements in pharmaceutical research.

Conclusion

Hidemi Masumura's contributions to the field of pharmaceuticals, particularly through his patent for an antidiabetic agent, highlight his role as an influential inventor. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…